Funds · SABS

Who owns SABS?

Institutional ownership of SAB Biotherapeutics Inc. from Form 13F, Q2 2026

87 institutional managers reported holding SAB Biotherapeutics Inc. (SABS) in Form 13F filings for Q2 2026, with 68,398,064 shares worth $267M. The largest reported holder was Caligan Partners LP. Managers that filed both quarters cut a net 1,568,830 shares (-2.3%). 31 opened new positions and 21 sold out.

Funds holding
87
Value held
$267M
New / sold out
31 / 21
Net shares, same filers
-2.3%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of SABS

FundValueShare of 13F holdingsSharesMove
Caligan Partners LP$31.1M11.6%7,967,207Unchanged
Vivo Capital, LLC$28.5M10.7%7,299,909Trimmed
Perceptive Advisors LLC$25.8M9.7%6,627,501Added
Adage Capital Partners GP, L.l.c.$25.0M9.4%6,405,553Added
Ra Capital Management, L.p.$17.2M6.4%4,401,500Unchanged
Balyasny Asset Management L.P.$14.7M5.5%3,760,439Unchanged
BlackRock, Inc.$12.0M4.5%3,066,016Added
Vanguard Capital Management LLC$11.6M4.3%2,972,929Added
Commodore Capital LP$11.2M4.2%2,870,000Trimmed
Millennium Management LLC$10.7M4.0%2,749,087Trimmed
Spruce Street Capital LP$8.6M3.2%2,198,502Unchanged
Sessa Capital IM, L.P.$8.6M3.2%2,198,457Unchanged
Affinity Asset Advisors, LLC$5.9M2.2%1,525,000Added
Boothbay Fund Management, LLC$5.8M2.2%1,481,660Unchanged
Geode Capital Management, LLC$5.0M1.9%1,277,185Added
Woodline Partners LP$4.6M1.7%1,180,355Trimmed
Ensign Peak Advisors, Inc$4.6M1.7%1,172,641Trimmed
Propel Bio Management, LLC$4.2M1.6%1,076,578Added
Soleus Capital Management, L.P.$3.5M1.3%900,000Trimmed
Seven Fleet Capital Management LP$2.9M1.1%736,077Added
Ameriprise Financial Inc$2.4M0.9%611,019Trimmed
State Street Corp$2.1M0.8%530,831Added
Susquehanna International Group, LLP$1.7M0.6%438,515New
DV Equities, LLC$1.6M0.6%400,000First report
AWM Investment Company, Inc.$1.5M0.5%375,000Trimmed

Share of 13F holdings is each fund's shares as a share of the 68,398,064 SABS shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $48.4M and sold $54.2M; 25 added and 16 trimmed.

Schedule 13D and 13G filings on SABS

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about SABS ownership

Who owns SABS stock?
87 institutional investment managers reported SABS positions in their Form 13F filings for Q2 2026, holding 68,398,064 shares worth $267M in total. Caligan Partners LP reported the largest position.
Are funds buying or selling SABS?
In Q2 2026, 31 managers opened new SABS positions, 25 added, 16 trimmed and 21 sold out. Managers that filed in both quarters sold a net 1,568,830 shares.
How current is this SABS institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to SABS by CUSIP. Options are left out. SABS news and filings · SABS insider trades · Top funds